View in EDS HTML Full Text PDF Full Text

A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy.

Saved in:
Bibliographic Details
Title: A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy.
Authors: Nath, Karthik1 (AUTHOR), Shekarkhand, Tala2 (AUTHOR), Salcedo, Meghan2 (AUTHOR), Derkach, Andriy3 (AUTHOR), Rueda, Siobhan4 (AUTHOR), Chansakul, Aisara5 (AUTHOR), Hulcrantz, Malin2 (AUTHOR), Korde, Neha2 (AUTHOR), Shah, Urvi A.2 (AUTHOR), Tan, Carlyn2 (AUTHOR), Chung, David J.1,6 (AUTHOR), Lahoud, Oscar B.6 (AUTHOR), Hassoun, Hani2 (AUTHOR), Lesokhin, Alexander M.1,2 (AUTHOR), Landau, Heather J.6 (AUTHOR), Shah, Gunjan1,6 (AUTHOR), Scordo, Michael1,6 (AUTHOR), Giralt, Sergio A.1,6 (AUTHOR), Usmani, Saad Z.1,2 (AUTHOR), Roshal, Mikhail7 (AUTHOR)
Source: Leukemia & Lymphoma. Dec2022, Vol. 63 Issue 14, p3488-3492. 5p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428194.2022.2131417